The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

The World Health Organisation (WHO) has endorsed the use of the long-acting injectable antiretroviral drug lenacapavir for ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

Black women make up just 13% of the U.S. female population, yet they account for over 50% of new HIV diagnoses among women, according to the Kaiser Family Foundation (KFF). That means more than half ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world ...

For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

At Essence Festival’s Global Black Economic Forum, Braxton joined Dr. Contessa and Raheem DeVaughn to speak candidly about HIV prevention, breast health, and taking control of your body.

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...